Avita Medical Inc.

Last updated September 27, 2026

Organization details

Legal name
Avita Medical Inc.
Former names
Avita Therapeutics, Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
3841 — Surgical & Medical Instruments & Apparatus
Jurisdiction of incorporation
Delaware
Headquarters city
Valencia
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
RCEL
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001762303
EIN
20-2578762
Wikidata ID
Q4828994

Board of directors

Chief executives

James Corbett · CEO
Dates unknown
Cary Guy Vance · President and CEO
Dates unknown

Director election results

Annual meeting of June 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

3 of this board's directors also sit on 5 other boards. 3 are in the same sector.

Network of Avita Medical Inc.'s board connections AngioDynamics Inc. AngioDynamics Inc. Alpha Teknova Inc. Alpha Teknova Inc. GMR Solutions Inc. GMR Solutions Inc. Stepan Company Stepan Company Xtant Medical Holdings Inc. Xtant Medical Holdings... Jan Stern Reed Jan Stern Reed Michael E. Tarnoff Michael E. Tarnoff Robert McNamara Robert McNamara Avita Medical Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$226,654
13 purchases by 2 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Jun 12, 2026 O'Toole David D Officer (CFO) Grant or award +2,000 $3.97 $7,940
Jun 9, 2026 Joseph Fralin Woody Director Open-market purchase +5,200 $4.00 $20,800
Jun 9, 2026 Joseph Fralin Woody Director Open-market purchase +5,000 $4.20 $21,000
Jun 9, 2026 Joseph Fralin Woody Director Open-market purchase +5,000 $4.18 $20,900
Jun 3, 2026 Joseph Fralin Woody Director Open-market purchase +5,000 $4.10 $20,500
Jun 3, 2026 Joseph Fralin Woody Director Open-market purchase +5,000 $4.09 $20,450
Jun 2, 2026 Joseph Fralin Woody Director Open-market purchase +5,000 $4.18 $20,900
Jun 2, 2026 Joseph Fralin Woody Director Open-market purchase +5,000 $4.21 $21,050
Jun 1, 2026 Joseph Fralin Woody Director Open-market purchase +5,000 $4.34 $21,700
Jun 1, 2026 Joseph Fralin Woody Director Open-market purchase +5,000 $4.26 $21,300
May 29, 2026 O'Toole David D Officer (CFO) Grant or award +5,000 $3.05 $15,250
May 29, 2026 Cary Guy Vance Director, Officer (President and CEO) Grant or award +5,000 $3.05 $15,250
May 20, 2026 O'Toole David D Officer (CFO) Open-market purchase +2,000 $4.26 $8,520
May 19, 2026 O'Toole David D Officer (CFO) Open-market purchase +2,000 $4.24 $8,480
Mar 11, 2026 O'Toole David D Officer (CFO) Open-market purchase +1,800 $4.78 $8,604

Organizations in the same sector, closest in location and size first.

Questions about Avita Medical Inc.

Who is the CEO of Avita Medical Inc.?

James Corbett is Avita Medical Inc.'s CEO.

How many directors are on Avita Medical Inc.'s board?

Avita Medical Inc.'s board has 9 directors: Cary Guy Vance, James Corbett, Jan Stern Reed, Jeremy Curnock Cook, Joseph Fralin Woody, Lou Panaccio, Michael E. Tarnoff, Robert McNamara and Suzanne Crowe.

Are Avita Medical Inc. insiders buying or selling shares?

Over the last 12 months, Avita Medical Inc. insiders bought $226,654 of shares in 13 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="avita-medical-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.